<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Neomycin and polymyxin B: Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Neomycin and polymyxin B: Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Neomycin and polymyxin B: Pediatric drug information</div><div class="clear"></div><div id="topicText"><div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
(For additional information <a class="drug drug_general" data-topicid="9687" href="/d/html/9687.html" rel="external">see "Neomycin and polymyxin B: Drug information"</a> and <a class="drug drug_patient" data-topicid="11804" href="/d/html/11804.html" rel="external">see "Neomycin and polymyxin B: Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="list canbnlist drugH1Div drugBrandNames" id="F52912168"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>Neosporin Irrigating Solution</li></ul></div>
<div class="list_set htclist drugH1Div drugBrandNames" id="F1048885"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Antibiotic, Topical</span>;</li>
<li>
<span class="list-set-name">Antibiotic, Urinary Irrigation</span>;</li>
<li>
<span class="list-set-name">Genitourinary Irrigant</span></li></ul></div>
<div class="block dop drugH1Div" id="F200585"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="34bad542-1213-47cb-94d2-53b56a25ab38">Urinary bladder irrigant</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Urinary bladder irrigant:</b> Limited data available (Elliott 2005); efficacy results variable (Warren 1978); most experience in patients with neurogenic bladder or spinal cord injury: Children and Adolescents: Irrigant solution (neomycin 40 mg/polymyxin B 200,000 units/L): Intravesical: 10 mL instilled at the end of each catheterization and retained until next catheterization (Mulcahy 1979); in older adolescents, 30 mL 2 to 3 times daily has been used for asymptomatic bacteriuria (Linsenmeyer 1999; Waites 2006). <b>Note:</b> Use has generally been replaced with other agents (eg, saline, gentamicin) (Defoor 2006; Dray 2017; van den Heijkant 2011; van Nieuwkoop 2010).</p></div>
</div>
<p style="text-indent:-2em;margin-left:2em;">
<b>Dosage adjustment for concomitant therapy:</b> Significant drug interactions exist, requiring dose/frequency adjustment or avoidance. Consult drug interactions database for more information.</p></div>
<div class="block dorp drugH1Div" id="F51130754"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">Children and Adolescents: In pediatric patients with ESRD, systemic absorption from the bladder may occur; use with caution and monitor serum levels (deJong 1993).</p></div>
<div class="block dohp drugH1Div" id="F51130755"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block doa drugH1Div" id="F200578"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="9687" href="/d/html/9687.html" rel="external">see "Neomycin and polymyxin B: Drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="34bad542-1213-47cb-94d2-53b56a25ab38">Urinary bladder irrigant</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:0em;display:inline">
<b>Urinary bladder irrigant:</b>
<b>Intravesical:</b> Add 1 mL irrigant to 1,000 mL isotonic saline solution per day as a continuous irrigation for up to 10 days.</p></div>
</div>
<p style="text-indent:-2em;margin-left:2em;">
<b>Dosage adjustment for concomitant therapy: </b>Significant drug interactions exist, requiring dose/frequency adjustment or avoidance. Consult drug interactions database for more information.</p></div>
<div class="block dora drugH1Div" id="F50991803"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling. Use with caution; systemic absorption is low, however, absorption from the denuded bladder surface has been reported and risk for toxicity is increased in patients with renal impairment.</p></div>
<div class="block doha drugH1Div" id="F50989079"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;margin-left:0em;margin-right:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block adr drugH1Div" id="F200558"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">Postmarketing: Genitourinary: Bladder mucosa irritation</p></div>
<div class="block coi drugH1Div" id="F200571"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to neomycin, polymyxin B, or any component of the formulation; history of a serious toxic reaction to an aminoglycoside</p></div>
<div class="block war drugH1Div" id="F49190070"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Concerns related to adverse effects:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Superinfection: Prolonged use may result in fungal or bacterial superinfection, including <i>C. difficile</i>-associated diarrhea (CDAD) and pseudomembranous colitis; CDAD has been observed &gt;2 months postantibiotic treatment.</p>
<p style="text-indent:-2em;margin-left:4em;">• Systemic toxicity: Ototoxicity, nephrotoxicity, and neuromuscular blockade may occur if systemically absorbed. Avoid use in patients with defects in the bladder mucosa or bladder wall (eg, vesical rupture) or in association with operative procedure on the bladder wall due to the risk of systemic toxicity; absorption of neomycin from the denuded bladder surface has been reported.</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Disease-related concerns:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Renal impairment: Use with caution in patients with renal impairment; risk for toxicity is increased.</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Special populations:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Dehydrated patients: Use with caution; risk for toxicity is increased.</p>
<p style="text-indent:-2em;margin-left:4em;">• Older adult: Use with caution; risk for toxicity is increased.</p>
<p style="text-indent:-2em;margin-left:4em;">• Pediatric: Use with caution in infants; risk for toxicity is increased.</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Other warnings/precautions: </b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: Irrigant is for urinary bladder irrigation only. Risk of systemic toxicity is low if irrigation of intact urinary bladder does not exceed 10 days.</p>
<p style="text-indent:-2em;margin-left:4em;">• Prolonged treatment: Patients receiving high doses of prolonged treatment are at increased risk for toxicity.</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F52878561"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">In general, systemic absorption from the bladder not usually observed (Chamberlain 1976). Ototoxicity has been reported in a 5 year old child with end-stage renal disease (ESRD) receiving neomycin 3 times weekly bladder irrigation for 6 weeks; at time ototoxicity reported, the serum neomycin concentration was 16 mg/L and persisted for 1 week (de Jong 1993).</p></div>
<div class="block foc drugH1Div" id="F200565"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;">Solution, irrigation:</p>
<p style="text-indent:-2em;margin-left:4em;">Generic: Neomycin 40 mg and polymyxin B sulfate 200,000 units per 1 mL (1 mL, 20 mL)</p></div>
<div class="block geq drugH1Div" id="F200552"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F16323487"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Neosporin GU Irrigant Irrigation)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">40-200000 (20 mL): $415.55</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>The pricing data provide a representative AWP and/or AAWP price from a single manufacturer of the brand and/or generic product, respectively. The pricing data should be used for benchmarking purposes only, and as such should not be used to set or adjudicate any prices for reimbursement or purchasing functions. Pricing data is updated monthly.</p></div>
<div class="block admp drugH1Div" id="F52613404"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Bladder irrigant: Do not inject irrigant solution; concentrated irrigant solution must be diluted prior to administration.</p>
<p style="text-indent:-2em;margin-left:2em;">Intermittent irrigation: Children and Adolescents: Attach to urinary catheter and instill dose volume at the end of catheterization (Huynh 2011; Linsenmeyer 1999; Mulcahy 1979; Waites 2006).</p></div>
<div class="block adm drugH1Div" id="F200568"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">For bladder irrigation only; not for injection. Connect irrigation container to the inflow lumen of a 3-way catheter to permit continuous irrigation of the urinary bladder. Rinsing of the bladder should be <b>continuous</b>; the inflow or rinse solution should not be interrupted for more than a few minutes. Adjust flow rate to 1,000 mL/24 hours; if patient’s urine output exceeds 2,000 mL/day, increase flow rate to 2,000 mL/24 hours.</p></div>
<div class="block sts drugH1Div" id="F200575"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:0em;display:inline">Store at 2°C to 8°C (36°F to 46°F). Prepared dilutions should be stored in the refrigerator and discarded after 48 hours.</p></div>
<div class="block usep drugH1Div" id="F53567989"><span class="drugH1">Use</span>
<p style="text-indent:0em;display:inline">Continuous irrigant or rinse for short-term (up to 10 days) in the urinary bladder of abacteriuric patients to help prevent bacteriuria and gram-negative rod septicemia associated with the use of indwelling catheters (FDA approved in adults)</p></div>
<div class="block cyt drugH1Div" id="F13299752"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F200559"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block pri drugH1Div" id="F7413693"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Animal reproduction studies have not been conducted with this combination; however, there are reports of total irreversible bilateral congenital deafness in children whose mothers received streptomycin during pregnancy. See individual monographs for additional information.</p></div>
<div class="block mopp drugH1Div" id="F53567970"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Urinalysis, renal function; serum neomycin concentrations in select patients (renal impairment, long duration or retention/use)</p></div>
<div class="block pha drugH1Div" id="F200555"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:-2em;margin-left:2em;">Neomycin: Interferes with bacterial protein synthesis by binding to 30S ribosomal subunits.</p>
<p style="text-indent:-2em;margin-left:2em;">Polymyxin B: Binds to phospholipids, alters permeability, and damages the bacterial cytoplasmic membrane permitting leakage of intracellular constituents.</p></div>
<div class="block phk drugH1Div" id="F200570"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:0em;text-align:justify;display:inline">See individual agents.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Absorption: Topical: Clinically insignificant amounts of neomycin and polymyxin B are absorbed following irrigation of an intact urinary bladder. Systemic absorption may occur from a denuded bladder.</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F200572"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Neoronin</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Neosporin gu irrigant sterile</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-181601">
<a name="181601"></a>Chamberlain G, Needham P. The absorption of antibiotics from the bladder. <i>J Urol</i>. 1976;116(2):172-173.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/neomycin-and-polymyxin-b-pediatric-drug-information/abstract-text/181601/pubmed" id="181601" target="_blank">181601</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16600780">
<a name="16600780"></a>Defoor W, Ferguson D, Mashni S, et al. Safety of gentamicin bladder irrigations in complex urological cases. <i>J Urol</i>. 2006;175(5):1861-1864.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/neomycin-and-polymyxin-b-pediatric-drug-information/abstract-text/16600780/pubmed" id="16600780" target="_blank">16600780</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8371390">
<a name="8371390"></a>de Jong TP, Donckerwolcke RA, Boemers TM. Neomycin toxicity in bladder irrigation. <i>J Urol</i>. 1993;150(4):1199.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/neomycin-and-polymyxin-b-pediatric-drug-information/abstract-text/8371390/pubmed" id="8371390" target="_blank">8371390</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28791235">
<a name="28791235"></a>Dray EV, Clemens JQ. Recurrent urinary tract infections in patients with incomplete bladder emptying: is there a role for intravesical therapy? <i>Transl Androl Urol</i>. 2017;6(Suppl 2):S163-S170.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/neomycin-and-polymyxin-b-pediatric-drug-information/abstract-text/28791235/pubmed" id="28791235" target="_blank">28791235</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15592079">
<a name="15592079"></a>Elliott SP, Villar R, Duncan B. Bacteriuria management and urological evaluation of patients with spina bifida and neurogenic bladder: a multicenter survey. <i>J Urol</i>. 2005;173(1):217-220.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/neomycin-and-polymyxin-b-pediatric-drug-information/abstract-text/15592079/pubmed" id="15592079" target="_blank">15592079</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22477833">
<a name="22477833"></a>Huynh D, Morgan JA. Use of intravesicular amikacin irrigations for the treatment and prophylaxis of urinary tract infections in a patient with spina bifida and neurogenic bladder: a case report. <i>J Pediatr Pharmacol Ther</i>. 2011;16(2):102-107.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/neomycin-and-polymyxin-b-pediatric-drug-information/abstract-text/22477833/pubmed" id="22477833" target="_blank">22477833</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10751129">
<a name="10751129"></a>Linsenmeyer TA, Jain A, Thompson BW. Effectiveness of neomycin/polymyxin bladder irrigation to treat resistant urinary pathogens in those with spinal cord injury. <i>J Spinal Cord Med</i>. 1999;22(4):252-257.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/neomycin-and-polymyxin-b-pediatric-drug-information/abstract-text/10751129/pubmed" id="10751129" target="_blank">10751129</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-220767">
<a name="220767"></a>Mulcahy JJ, James HE. Management of neurogenic bladder in infancy and childhood. <i>Urology</i>. 1979;13(3):235-240.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/neomycin-and-polymyxin-b-pediatric-drug-information/abstract-text/220767/pubmed" id="220767" target="_blank">220767</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Neosporin GU Irrigant (neomycin sulfate/polymyxin B sulfate) [prescribing information]. New York, NY: Pfizer Inc; September 2016</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21553274">
<a name="21553274"></a>van den Heijkant M, Haider N, Taylor C, Subramaniam R. Efficacy of bladder irrigation and surveillance program in prevention of urinary tract infections and bladder calculi in children with an ileocystoplasty and bladder neck repair. <i>Pediatr Surg Int</i>. 2011;27(7):781-785.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/neomycin-and-polymyxin-b-pediatric-drug-information/abstract-text/21553274/pubmed" id="21553274" target="_blank">21553274</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20580533">
<a name="20580533"></a>van Nieuwkoop C, den Exter PL, Elzevier HW, den Hartigh J, van Dissel JT. Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation. <i>Int J Antimicrob Agents</i>. 2010;36(6):485-490.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/neomycin-and-polymyxin-b-pediatric-drug-information/abstract-text/20580533/pubmed" id="20580533" target="_blank">20580533</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16859225">
<a name="16859225"></a>Waites KB, Canupp KC, Roper JF, Camp SM, Chen Y. Evaluation of 3 methods of bladder irrigation to treat bacteriuria in persons with neurogenic bladder. <i>J Spinal Cord Med</i>. 2006;29(3):217-226.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/neomycin-and-polymyxin-b-pediatric-drug-information/abstract-text/16859225/pubmed" id="16859225" target="_blank">16859225</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-210379">
<a name="210379"></a>Warren JW, Platt R, Thomas RJ, Rosner B, Kass EH. Antibiotic irrigation and catheter-associated urinary-tract infections. <i>N Engl J Med</i>. 1978;299(11):570-573.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/neomycin-and-polymyxin-b-pediatric-drug-information/abstract-text/210379/pubmed" id="210379" target="_blank">210379</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 12635 Version 161.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
